This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greenway’s PrimeRESEARCH To Exhibit At DIA 2012 Annual Meeting

Greenway Medical Technologies, Inc., provider of the single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE®, is exhibiting its PrimeRESEARCH™ solutions at the DIA 2012 48th Annual Meeting June 24-28 in Philadelphia.

PrimeRESEARCH’s EHR-enabled technology connects life science companies and contract research organizations (CROs) with physician practices that use PrimeSUITE to document patient health records.

To date, Greenway® has coordinated participation of PrimeRESEARCH sites in more than 40 clinical studies, including Phase II-IV, Observational, Registry and Safety studies, across a range of therapeutic areas.

Using de-identified queries run across the PrimeRESEARCH network, Greenway helps study sponsors and CROs test the feasibility of study protocols and identify sites with sufficient patient population. Study-eligible patients are then identified to participating sites based on protocol inclusion and exclusion criteria to facilitate recruitment. This reduces the need for time-consuming chart searches by site staff. Eligibility can be flagged within PrimeSUITE at the point of care, and data for enrolled patients can be extracted from PrimeSUITE and loaded into a study database or mapped into an electronic data capture (EDC) case report form, decreasing duplicate data entry and making study participation easier for sites.

“We have seen high levels of sponsor and CRO satisfaction with our innovative options for investigator site selection, patient recruitment, data collection and monitoring,” said Greenway Vice President of PrimeRESEARCH Sam Holliday. “Our integrated remote monitoring solution has been particularly effective in reducing the amount of on-site source document verification and providing early detection of protocol deviations and serious adverse events (SAEs).”

The PrimeRESEARCH Remote Monitoring Solution (RMS) enables sponsors and CROs to perform more flexible and efficient source document verification and reduce on-site visits through view-only access to health records of enrolled subjects via a secure, online portal that includes a full audit trail.

“The goal of PrimeRESEARCH is to improve population heath by connecting life science companies developing new treatments to practices whose patients may benefit from these therapies,” said Greenway President and CEO Tee Green. “Greenway continues to grow its network of PrimeRESEARCH sites and add innovative capabilities that contribute to the advancement of medical knowledge, improve the speed and lower the cost of clinical research, and ultimately benefit healthcare providers, patients and the life science industry.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs